PDF herunterladen
Semin Neurol
DOI: 10.1055/s-0044-1791693
Invited Review

Infectious Neuropathies

Mitali Mehta
1   Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York
,
Jessica Robinson-Papp
1   Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, New York
› Institutsangaben Funding Dr. Robinson-Papp is supported by grants from the NIH including: R01DK122853. Dr. Robinson-Papp has received NIH grant funding to investigate HIV-associated neuropathies and diabetic neuropathic pain. Additionally, royalties have been received from UpToDate for articles on neuropathy. Speaker honoraria have been received from the American Academy of Neurology and the Clinical Education Initiative. The aforementioned NIH grants include funds for travel to academic meetings. Dr. Robinson-Papp also serves as a Scientific Advisory Board Member for Neuropathix, Inc. and Immgenuity Inc.
› Weitere Informationen
    Lizenzen und Reprints

Abstract

This review explores diverse infectious etiologies of peripheral nervous system (PNS) dysfunction, spanning sensory and motor neurons, nerves, and associated structures. Progress in viral and bacterial infections reveals multifaceted mechanisms underlying neuropathies, including viral neurotoxicity and immune-mediated responses. Latest diagnostic advances facilitate early PNS complication detection, with ongoing research offering promising treatment avenues. Emerging pathogens like severe acute respiratory syndrome coronavirus 2, Zika virus, and EV-D68 highlight the evolving infectious neuropathy paradigm. Recognizing characteristic patterns and integrating clinical factors are pivotal for precise diagnosis and tailored intervention. Challenges persist in assessment and management due to varied pathogenic mechanisms. Advancements in understanding pathogenesis have improved targeted therapies, yet gaps remain in effective treatments. Ongoing research is crucial for optimizing approaches and improving patient outcomes.

Keywords

peripheral neuropathies - distal symmetrical - sensory-predominant polyneuropathy - HIV infection - demyelinating neuropathy


Publikationsverlauf

Artikel online veröffentlicht:
11. Oktober 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Gabbai AA, Castelo A, Oliveira AS. HIV peripheral neuropathy. Handb Clin Neurol 2013; 115: 515-529
    CrossrefPubMedGoogle Scholar
  • 2 Widyadharma IPE, Barus J, Dewi PR, Yaputra F, Adnyana IMO, Samatra D. Glial cells involvement in pathogenesis of human immunodeficiency virus-associated sensory neuropathy (HIV-SN): literature review. Int J Med Rev Case Rep 2018; 2 (03) 49-52
    CrossrefPubMedGoogle Scholar
  • 3 Roda RH, Hoke A. Mitochondrial dysfunction in HIV-induced peripheral neuropathy. Int Rev Neurobiol 2019; 145: 67-82
    CrossrefPubMedGoogle Scholar
  • 4 Cherry CL, Wadley AL, Kamerman PR. Painful HIV-associated sensory neuropathy. Pain Manag (Lond) 2012; 2 (06) 543-552
    CrossrefPubMedGoogle Scholar
  • 5 Boustani A, Kulbe JR, Andalibi MS, Pérez-Santiago J, Mehta SR, Ellis RJ. et al. Mitochondrial DNA and electron transport chain protein levels are altered in peripheral nerve tissues from donors with HIV sensory neuropathy: a pilot study. Int J Mol Sci 2024; 25 (09) 4732
    CrossrefPubMedGoogle Scholar
  • 6 Kranick SM, Nath A. Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy. Continuum (Minneap Minn) 2012; 18 (6 Infectious Disease): 1319-1337
    PubMedGoogle Scholar
  • 7 Peltier AC, Russell JW. Recent advances in drug-induced neuropathies. Curr Opin Neurol 2002; 15 (05) 633-638
    CrossrefPubMedGoogle Scholar
  • 8 Callaghan BC, Price RS, Feldman EL. Distal symmetric polyneuropathy: a review. JAMA 2015; 314 (20) 2172-2181
    CrossrefPubMedGoogle Scholar
  • 9 Dimitrova A, Murchison C, Oken B. Acupuncture for the treatment of peripheral neuropathy: a systematic review and meta-analysis. J Altern Complement Med 2017; 23 (03) 164-179
    CrossrefPubMedGoogle Scholar
  • 10 Chow D, Nakamoto BK, Sullivan K. et al. Symptoms of autonomic dysfunction in human immunodeficiency virus. Open Forum Infect Dis 2015; 2 (03) ofv103
    CrossrefPubMedGoogle Scholar
  • 11 Zilliox L, Peltier AC, Wren PA. et al. Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms. Neurology 2011; 76 (12) 1099-1105
    CrossrefPubMedGoogle Scholar
  • 12 Robinson-Papp J, Sharma SK. Autonomic neuropathy in HIV is unrecognized and associated with medical morbidity. AIDS Patient Care STDs 2013; 27 (10) 539-543
    CrossrefPubMedGoogle Scholar
  • 13 Jiao J, Simpson DM, Robinson-Papp J. HIV-Related Peripheral Nervous System Illness. New York, NY: Springer; 2017: 209-227
    Google Scholar
  • 14 Sletten DM, Suarez GA, Low PA, Mandrekar J, Singer W. COMPASS 31: a refined and abbreviated Composite Autonomic Symptom Score. Mayo Clin Proc 2012; 87 (12) 1196-1201
    CrossrefPubMedGoogle Scholar
  • 15 Steiner I. Chapter 31 - Herpes virus infection of the peripheral nervous system. In: Said G, Krarup C. eds. Handbook of Clinical Neurology. Amsterdam, Netherlands: Elsevier; 2013: 543-558
    Google Scholar
  • 16 Kim YS, Hollander H. Polyradiculopathy due to cytomegalovirus: report of two cases in which improvement occurred after prolonged therapy and review of the literature. Clin Infect Dis 1993; 17 (01) 32-37
    CrossrefPubMedGoogle Scholar
  • 17 Shah HA, Meiwald A, Perera C, Casabona G, Richmond P, Jamet N. Global prevalence of varicella-associated complications: a systematic review and meta-analysis. Infect Dis Ther 2024; 13 (01) 79-103
    CrossrefPubMedGoogle Scholar
  • 18 Rab SM, Choudhury GM. Landry-Guillain-Barre syndrome after chicken pox. N Engl J Med 1963; 268 (04) 200-201
    CrossrefPubMedGoogle Scholar
  • 19 Zhou J, Li J, Ma L, Cao S. Zoster sine herpete: a review. Korean J Pain 2020; 33 (03) 208-215
    CrossrefPubMedGoogle Scholar
  • 20 Gilden D. Efficacy of live zoster vaccine in preventing zoster and postherpetic neuralgia. J Intern Med 2011; 269 (05) 496-506
    CrossrefPubMedGoogle Scholar
  • 21 Umehara T, Sengoku R, Mitsumura H, Mochio S. Neurological picture. Findings of segmental zoster paresis on MRI. J Neurol Neurosurg Psychiatry 2011; 82 (06) 694-694
    CrossrefPubMedGoogle Scholar
  • 22 Choi J-Y, Kang CH, Kim B-J, Park K-W, Yu S-W. Brachial plexopathy following herpes zoster infection: two cases with MRI findings. J Neurol Sci 2009; 285 (1–2): 224-226
    CrossrefPubMedGoogle Scholar
  • 23 James C, Harfouche M, Welton NJ. et al. Herpes simplex virus: global infection prevalence and incidence estimates, 2016. Bull World Health Organ 2020; 98 (05) 315-329
    CrossrefPubMedGoogle Scholar
  • 24 Cole S. Herpes simplex virus: epidemiology, diagnosis, and treatment. Nurs Clin North Am 2020; 55 (03) 337-345
    CrossrefPubMedGoogle Scholar
  • 25 Carod-Artal FJ. Infectious diseases causing autonomic dysfunction. Clin Auton Res 2018; 28 (01) 67-81
    CrossrefPubMedGoogle Scholar
  • 26 Berger JR, Houff S. Neurological complications of herpes simplex virus type 2 infection. Arch Neurol 2008; 65 (05) 596-600
    CrossrefPubMedGoogle Scholar
  • 27 Handler CE, Perkin GD. Radiculomyelopathy due to genital herpes. Lancet 1982; 2 (8305): 987-988
    CrossrefPubMedGoogle Scholar
  • 28 Craig CP, Nahmias AJ. Different patterns of neurologic involvement with herpes simplex virus types 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J Infect Dis 1973; 127 (04) 365-372
    CrossrefPubMedGoogle Scholar
  • 29 Gilbert SC. Bell's palsy and herpesviruses. Herpes 2002; 9 (03) 70-73
    PubMedGoogle Scholar
  • 30 Neville BG, Sladen GE. Acute autonomic neuropathy following primary herpes simplex infection. J Neurol Neurosurg Psychiatry 1984; 47 (06) 648-650
    CrossrefPubMedGoogle Scholar
  • 31 Küker W, Schaade L, Ritter K, Nacimiento W. MRI follow-up of herpes simplex virus (type 1) radiculomyelitis. Neurology 1999; 52 (05) 1102-1103
    CrossrefPubMedGoogle Scholar
  • 32 Handley G, Pankow S, Bard JD, Yee R, Nigo M, Hasbun R. Distinguishing cytomegalovirus meningoencephalitis from other viral central nervous system infections. J Clin Virol 2021; 142: 104936
    CrossrefPubMedGoogle Scholar
  • 33 Leung J, Sejvar JJ, Soares J, Lanzieri TM. Guillain-Barré syndrome and antecedent cytomegalovirus infection, USA 2009-2015. Neurol Sci 2020; 41 (04) 885-891
    CrossrefPubMedGoogle Scholar
  • 34 Lefeuvre L, Schibler M, Lalive PH. Elsberg syndrome secondary to cytomegalovirus infection in an immunocompetent patient. A case report. Neurol Neuroimmunol Neuroinflamm 2022; 10 (02) e200079
    CrossrefPubMedGoogle Scholar
  • 35 Abrantes J, Torres DS, Brandão-Mello CE. The many difficulties and subtleties in the cognitive assessment of chronic hepatitis C infection. Int J Hepatol 2020; 2020: 9675235
    CrossrefPubMedGoogle Scholar
  • 36 Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003; 74 (09) 1267-1271
    CrossrefPubMedGoogle Scholar
  • 37 Vital C, Vital A, Canron MH. et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst 2006; 11 (01) 20-29
    CrossrefPubMedGoogle Scholar
  • 38 Adinolfi LE, Nevola R, Lus G. et al. Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview. World J Gastroenterol 2015; 21 (08) 2269-2280
    CrossrefPubMedGoogle Scholar
  • 39 Fornero L, Kanouni T, Tudesq JJ. et al. Preventive plasmapheresis for rituximab related flare in cryoglobulinemic vasculitis. J Transl Autoimmun 2023; 6: 100194
    CrossrefPubMedGoogle Scholar
  • 40 Arandjelovic S, Bonaci-Nikolic B, Peric-Popadic A. et al. HCV related severe cryoglobulinemic vasculitis treated with plasma exchange and rituximab: case report and literature review. J Infect Dev Ctries 2017; 11 (05) 431-436
    CrossrefPubMedGoogle Scholar
  • 41 Bureau BL, Obeidat A, Dhariwal MS, Jha P. Peripheral neuropathy as a complication of SARS-Cov-2. Cureus 2020; 12 (11) e11452
    PubMedGoogle Scholar
  • 42 Gholami M, Safari S, Ulloa L, Motaghinejad M. Neuropathies and neurological dysfunction induced by coronaviruses. J Neurovirol 2021; 27 (03) 380-396
    CrossrefPubMedGoogle Scholar
  • 43 Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the nervous system. Cell 2020; 183 (01) 16-27.e1
    CrossrefPubMedGoogle Scholar
  • 44 Destras G, Bal A, Escuret V, Morfin F, Lina B, Josset L. COVID-Diagnosis HCL Study Group. Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic. Lancet Microbe 2020; 1 (04) e149
    CrossrefPubMedGoogle Scholar
  • 45 Oaklander AL, Mills AJ, Kelley M. et al. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm 2022; 9 (03) e1146
    CrossrefPubMedGoogle Scholar
  • 46 Finsterer J, Scorza FA, Scorza C, Fiorini A. COVID-19 associated cranial nerve neuropathy: a systematic review. Bosn J Basic Med Sci 2022; 22 (01) 39-45
    PubMedGoogle Scholar
  • 47 Abu-Rumeileh S, Garibashvili T, Ruf W. et al. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. J Neurol Sci 2020; 418: 117106
    CrossrefPubMedGoogle Scholar
  • 48 Brugliera L, Filippi M, Del Carro U. et al. Nerve compression injuries after prolonged prone position ventilation in patients with SARS-CoV-2: a case series. Arch Phys Med Rehabil 2021; 102 (03) 359-362
    CrossrefPubMedGoogle Scholar
  • 49 Abrams RMC, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve 2022; 65 (04) 440-443
    CrossrefPubMedGoogle Scholar
  • 50 Koyun D. Neurological complication caused by zika virus: Guillain-Barré syndrome. Int J Biomed Clin Anal 2022; 2 (01) 20-28
    PubMedGoogle Scholar
  • 51 Kazmi SS, Ali W, Bibi N, Nouroz F. A review on Zika virus outbreak, epidemiology, transmission and infection dynamics. J Biol Res (Thessalon) 2020; 27: 5
    CrossrefPubMedGoogle Scholar
  • 52 Carod-Artal FJ. Neurological complications of Zika virus infection. Expert Rev Anti Infect Ther 2018; 16 (05) 399-410
    CrossrefPubMedGoogle Scholar
  • 53 Tyler KL, Roos KL. The expanding spectrum of Zika virus infections of the nervous system. JAMA Neurol 2017; 74 (10) 1169-1171
    CrossrefPubMedGoogle Scholar
  • 54 Adi-Dako O, Kwapong AA, Adukpo S. Zika Virus Disease: Rising Contagious Diseases. Hoboken, NJ:
    Google Scholar
  • 55 Bhandari R, Gupta R, Vashishth A, Kuhad A. Transient receptor potential vanilloid 1 (TRPV1) as a plausible novel therapeutic target for treating neurological complications in ZikaVirus. Med Hypotheses 2021; 156: 110685
    CrossrefPubMedGoogle Scholar
  • 56 Punsoni M, Lakis NS, Mellion M, de la Monte SM. Post-polio syndrome revisited. Neurol Int 2023; 15 (02) 569-579
    CrossrefPubMedGoogle Scholar
  • 57 Louis ED, Mayer SA. Merritt's Neurology. Philadelphia, PA: Lippincott Williams & Wilkins; 2021
    Google Scholar
  • 58 Wasserstrom R, Mamourian AC, McGary CT, Miller G. Bulbar poliomyelitis: MR findings with pathologic correlation. AJNR Am J Neuroradiol 1992; 13 (01) 371-373
    PubMedGoogle Scholar
  • 59 Russo GB, Goyal T, Tyler K, Thakur KT. Re-emergence of poliovirus in the United States: considerations and implications. Ann Neurol 2022; 92 (05) 725-728
    CrossrefPubMedGoogle Scholar
  • 60 Bai F, Thompson EA, Vig PJS, Leis AA. Current understanding of West Nile virus clinical manifestations, immune responses, neuroinvasion, and immunotherapeutic implications. Pathogens 2019; 8 (04) 193
    CrossrefPubMedGoogle Scholar
  • 61 Gray TJ, Webb CE. A review of the epidemiological and clinical aspects of West Nile virus. Int J Gen Med 2014; 7: 193-203
    CrossrefPubMedGoogle Scholar
  • 62 Boegle AK, Narayanaswami P. Infectious neuropathies. Continuum (Minneap Minn) 2023; 29 (05) 1418-1443
    PubMedGoogle Scholar
  • 63 Hiraldo JDG, Fuerte-Hortigón A, Domínguez-Mayoral A. et al. Uncovering the neurological effects of West Nile virus during a record-breaking southern Spain outbreak in 2020-2021. J Neuroimmunol 2023; 383: 578179
    CrossrefPubMedGoogle Scholar
  • 64 Gilrane VL, Zhuge J, Huang W. et al. Biennial upsurge and molecular epidemiology of enterovirus D68 infection in New York, USA, 2014 to 2018. J Clin Microbiol 2020; 58 (09) e00284-20
    CrossrefPubMedGoogle Scholar
  • 65 Kidd S, Lopez AS, Konopka-Anstadt JL, Nix WA, Routh JA, Oberste MS. Enterovirus D68–associated acute flaccid myelitis, United States, 2020. Emerg Infect Dis 2020; 26 (10) e201630
    CrossrefPubMedGoogle Scholar
  • 66 Wang C, Li J, Liu Y, Sun Q, Liu Z. Pathogenesis of enterovirus infection in central nervous system. Biosaf Health 2023; 5 (04) 233-239
    CrossrefPubMedGoogle Scholar
  • 67 Sooksawasdi Na Ayudhya S, Laksono BM, van Riel D. The pathogenesis and virulence of enterovirus-D68 infection. Virulence 2021; 12 (01) 2060-2072
    CrossrefPubMedGoogle Scholar
  • 68 Musharrafieh R, Zhang J, Tuohy P. et al. Discovery of quinoline analogues as potent antivirals against enterovirus D68 (EV-D68). J Med Chem 2019; 62 (08) 4074-4090
    CrossrefPubMedGoogle Scholar
  • 69 Ulferts R, de Boer SM, van der Linden L. et al. Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C. Antimicrob Agents Chemother 2016; 60 (05) 2627-2638
    CrossrefPubMedGoogle Scholar
  • 70 Cardenas-de la Garza JA, De la Cruz-Valadez E, Ocampo-Candiani J, Welsh O. Clinical spectrum of Lyme disease. Eur J Clin Microbiol Infect Dis 2019; 38 (02) 201-208
    CrossrefPubMedGoogle Scholar
  • 71 Hansen K, Crone C, Kristoferitsch W. Lyme neuroborreliosis. Handb Clin Neurol 2013; 115: 559-575
    CrossrefPubMedGoogle Scholar
  • 72 Halperin JJ. Facial nerve palsy associated with lyme disease. Muscle Nerve 2003; 28 (04) 516-517
    CrossrefPubMedGoogle Scholar
  • 73 Wan L, Yan A, Reese E, Thomas J, Kissinger M. Through the eyes of uncertainty: giant cell arteritis and Lyme neuroborreliosis in a story of vision loss. Cureus 2024; 16 (02) e53623
    PubMedGoogle Scholar
  • 74 Omotosho YB, Sherchan R, Ying GW, Shayuk M. A unique case of bannwarth syndrome in early disseminated Lyme disease. Cureus 2021; 13 (04) e14680
    PubMedGoogle Scholar
  • 75 Novak P, Felsenstein D, Mao C, Octavien NR, Zubcevik N. Association of small fiber neuropathy and post treatment Lyme disease syndrome. PLoS One 2019; 14 (02) e0212222
    CrossrefPubMedGoogle Scholar
  • 76 Roos KL. Neurologic complications of Lyme disease. Continuum (Minneap Minn) 2021; 27 (04) 1040-1050
    PubMedGoogle Scholar
  • 77 Scollard D, Stryjewska B, Dacso M. Leprosy: Epidemiology, Microbiology, Clinical Manifestations, and Diagnosis. Waltham, MA: UpToDate; 2020
    Google Scholar
  • 78 Ebenezer GJ, Scollard DM. Treatment and evaluation advances in leprosy neuropathy. Neurotherapeutics 2021; 18 (04) 2337-2350
    CrossrefPubMedGoogle Scholar
  • 79 van Brakel WH, Khawas IB. Silent neuropathy in leprosy: an epidemiological description. Lepr Rev 1994; 65 (04) 350-360
    PubMedGoogle Scholar
  • 80 Gupta OP, Jain AP, Jajoo UN, Kumar K, Parvez K. Respiratory dysautonomia in leprosy. Indian J Lepr 1984; 56 (04) 844-846
    PubMedGoogle Scholar
  • 81 Khadilkar SV, Patil SB, Shetty VP. Neuropathies of leprosy. J Neurol Sci 2021; 420: 117288
    CrossrefPubMedGoogle Scholar
  • 82 Rao PN, Suneetha S. Pure neuritic leprosy: current status and relevance. Indian J Dermatol Venereol Leprol 2016; 82 (03) 252-261
    CrossrefPubMedGoogle Scholar
  • 83 Tsuboi M, Evans J, Davies EP. et al. Prevalence of syphilis among men who have sex with men: a global systematic review and meta-analysis from 2000-20. Lancet Glob Health 2021; 9 (08) e1110-e1118
    CrossrefPubMedGoogle Scholar
  • 84 Chaudhry S, Akinlusi I, Shi T, Cervantes J. Secondary syphilis: pathophysiology, clinical manifestations, and diagnostic testing. Venereology 2023; 2 (02) 65-75
    CrossrefPubMedGoogle Scholar
  • 85 Berger JR, Dean D. Neurosyphilis. Handb Clin Neurol 2014; 121: 1461-1472
    CrossrefPubMedGoogle Scholar
  • 86 Klein TA, Ridley MB. An old flame reignites: vagal neuropathy secondary to neurosyphilis. J Voice 2014; 28 (02) 255-257
    CrossrefPubMedGoogle Scholar
  • 87 Zhou J, Zhang H, Tang K, Liu R, Li J. An updated review of recent advances in neurosyphilis. Front Med (Lausanne) 2022; 9: 800383
    CrossrefPubMedGoogle Scholar
  • 88 Kayabaşı M, Köksaldı S, Saatci AO, Bajin MS. Presentation of ocular syphilis with bilateral optic neuropathy. Neuroophthalmology 2023; 47 (5–6): 274-280
    CrossrefPubMedGoogle Scholar
  • 89 Clarke KEN, MacNeil A, Hadler S, Scott C, Tiwari TSP, Cherian T. Global epidemiology of diphtheria, 2000–2017(1). Emerg Infect Dis 2019; 25 (10) 1834-1842
    CrossrefPubMedGoogle Scholar
  • 90 Lozhnikova SM, Pirogov VN, Piradov MA, Sakharova AV, Liudkovskaia IG. Diphtheritic polyneuropathy: clinico-morphologic study [in Russian]. Arkh Patol 1997; 59 (02) 11-17
    PubMedGoogle Scholar
  • 91 Joshua AM, Misri Z. Peripheral nerve disorders. In: Physiotherapy for Adult Neurological Conditions. New York, NY: Springer; 2022: 621-729
    CrossrefGoogle Scholar
  • 92 Kobaidze K, Wiley Z. Botulism in the 21st Century: a scoping review. . Brown Hospital Medicine 2023;2(02)
    PubMedGoogle Scholar
  • 93 Zhang J-C, Sun L, Nie Q-H. Botulism, where are we now?. Clin Toxicol (Phila) 2010; 48 (09) 867-879
    CrossrefPubMedGoogle Scholar
  • 94 Hehir II MK, Logigian EL. Infectious neuropathies. Continuum (Minneap Minn) 2014; 20 (5 Peripheral Nervous System Disorders): 1274-1292
    PubMedGoogle Scholar
  • 95 Howard Jr JF. Electrodiagnosis of disorders of neuromuscular transmission. Phys Med Rehabil Clin N Am 2013; 24 (01) 169-192
    CrossrefPubMedGoogle Scholar
  • 96 Zivković SA, Shipe C. Use of repetitive nerve stimulation in the evaluation of neuromuscular junction disorders. Am J Electroneurodiagn Technol 2005; 45 (04) 248-261
    CrossrefPubMedGoogle Scholar
  • 97 Echeverría LE, Marcus R, Novick G. et al. WHF IASC roadmap on Chagas disease. Glob Heart 2020; 15 (01) 26
    CrossrefPubMedGoogle Scholar
  • 98 Robinson-Papp J. Infectious neuropathies. Continuum (Minneap Minn) 2012; 18 (01) 126-138
    PubMedGoogle Scholar
  • 99 Sica RE, Gonzalez Cappa SM, Sanz OP, Mirkin G. Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis. Bull Soc Pathol Exot 1995; 88 (04) 156-163
    PubMedGoogle Scholar
  • 100 WHO Expert Committee. Control of Chagas disease. World Health Organ Tech Rep Ser 2002; 905: i-vi , 1–109, back cover
    PubMedGoogle Scholar